Oklahoma City-Optometrists in Oklahoma will no longer perform LASIK and other surgical procedures typically reserved for ophthalmologists after the state's attorney general revised his opinion on the scope of optometric surgery.
Carl Zeiss Meditec is generating a lot of noise within the ophthalmic industry. Over the last 2 years, Zeiss Meditec has undergone a transformation from the quiet division of a German technology foundation to becoming one of the leading players in the ophthalmic market.
Santa Ana, CA-Patients who either are severely myopic or fear laser surgery are one step closer to an alternative refractive treatment with the anticipated FDA approval of the Artisan/Verisyse phakic IOL (AMO).
Gamagori, Japan-Nidek Co. Ltd. is declaring victory in its longstanding legal battle with Summit Technologies Inc. (Alcon), but analysts are left to wonder whether it matters anymore.
The FDA soon will approve standards for contrast sensitivity testing in clinical trials. The approval is a step that will not only make the administration of this test easier for ophthalmologists but its comparison with clinical trial data and other testing centers simpler and more valuable as well.
San Diego-The San Diego medical landscape has just changed significantly with the opening of two new additions to the Shiley Eye Center: the Joan and Irwin Jacobs Retina Center and the Hamilton Glaucoma Center.
Anaheim, CA-"Careful preoperative evaluation of patients and appropriate perioperative and postoperative management are needed to modulate the healing response effectively and maximize the success rate of combined cataract and glaucoma surgery," said James C. Tsai, MD, at the American Acad- emy of Ophthalmology annual meeting.
Las Vegas-The investigational drug pegaptanib sodium (Macugen, Eyetech Pharmaceuticals) has been shown to stabilize and improve vision and showed effectiveness against all three subtypes of lesions involved in wet age-related macular degeneration (AMD), according to Lawrence J. Singerman, MD.